IL9 and hepatocellular carcinoma: Thus, IL-35 not only eliminated the function of CD8+ T cells in a direct way (12, 14, 16), but also reduced IL-9 production by CD4+ T cells, and in turn, would lead to a suppression in CD8+ T cell-mediated cytotoxicity in hepatitis and HCC patients.